In-vitro plant gene editing techniques that are used conventionally and have a long safety record are excluded from EU laws restricting the use of genetically modified organisms (GMOs), Europe's highest court said on Tuesday.
The long-running saga started in 2015 when a group of French agricultural associations took their grievance to a French court, saying plant varieties obtained via mutagenesis should not be exempt from GMO rules under French law.
The French court subsequently sought advice from the Luxembourg-based Court of Justice of the European Union (CJEU).
